AGP Wire

AGP

ROJAN FRAGRANCE TRADING (PTY) LTD said it is moving into phase two of its South Africa strategy, with plans to expand local operations, digital capabilities and partnerships.

AGP

AfriVest and the Traditional Leaders of Southern Africa signed a master partnership on 30 July 2026 to structure community-held assets into regulated digital instruments in South Africa.

AGP

The diagnostic catheters market is projected to rise from $4.5 billion in 2025 to $6.08 billion by 2030, according to The Business Research Company, as cardiovascular disease, imaging demand and minimally invasive procedures expand.

AGP

AITEC World has announced two global tourism gatherings for late 2026 in London and Addis Ababa, framing them as a push for more African travel, investment and trade.

AGP

Africa’s connected economy could stall unless regulators, operators and businesses build for network resilience, according to CommsCloud Managing Director Peter Walsh.

AGP

The Business Research Company says the nerve conduit market will grow from $2.17 billion in 2026 to $2.99 billion by 2030, driven by more peripheral nerve injuries, neurological disorders and demand for regenerative repair options.

AGP

The neurophysiology devices and equipment market is projected to grow from $1.76 billion in 2026 to $2.51 billion by 2030, driven by rising neurological disease rates, more point-of-care diagnostics and wider use of portable and wireless systems….

AGP

The nasal drug delivery technology market is projected to grow from $92.28 billion in 2026 to $129.23 billion by 2030, driven by demand for faster, non-invasive therapies and more work in CNS drugs and vaccines.

AGP

The Business Research Company says the global neurology devices market is on track to grow from $20.09 billion in 2025 to $35.94 billion by 2030, driven by rising neurological disease rates, new imaging tools and wider use of minimally invasive…

AGP

The next-generation sequencing informatics market is projected to grow from $11.96 billion in 2026 to $22.14 billion by 2030, driven by personalized medicine, cloud-based genomic platforms and AI tools.

AGP

The market for non-invasive cholesterol readers is projected to rise from $1.3 billion in 2025 to $2.63 billion by 2030, driven by cardiovascular disease prevalence, healthcare spending and demand for painless testing.

AGP

The global neurostimulation devices market is projected to grow from $6.86 billion in 2025 to $7.64 billion in 2026, as demand rises for treatments for chronic neurological conditions and pain.

AGP

The global market for non-PVC IV bags is projected to grow from $2.52 billion in 2026 to $3.8 billion by 2030, driven by demand for safer, more sustainable medical consumables and tighter material-safety rules.

AGP

The global neurorehabilitation devices market is projected to grow from $2.07 billion in 2025 to $3.58 billion by 2030, driven by rising neurological disorders, aging populations and demand for home-based recovery.

AGP

The neurosurgical robotics market is projected to grow from $4.74 billion in 2026 to $8.04 billion by 2030, according to The Business Research Company.

AGP

The non-invasive ventilators market is projected to grow from $3.05 billion in 2025 to $4.42 billion by 2030, according to The Business Research Company.

AGP

The nasal splints market is projected to grow from $7.07 billion in 2025 to $10.76 billion by 2030, driven by more nasal and septal surgeries, cosmetic rhinoplasty and demand for minimally invasive procedures.

AGP

The Business Research Company says the narcotics scanner market is expanding as drug trafficking, public safety concerns and border security spending rise.

AGP

The neuromodulation market is projected to grow from $8.45 billion in 2026 to $12.88 billion by 2030, according to The Business Research Company.

AGP

The Business Research Company projects the next generation sequencing market will grow from $16.31 billion in 2026 to $28.59 billion by 2030, driven by precision medicine, oncology diagnostics and wider genomics research.